Krishanu routes operators to the companies staring down an FDA finding, a launch date, a breach, or a search that will not close.
Public enforcement data, updated as it publishes — this is the market I watch.
- →Sante Manufacturing warned 5 June 2026 for CGMP violations, with every drug it offers for import already placed on Import Alert 66-40
- →Medline warned 28 May 2026 after an inspection found gaps in its own corrective actions, having suspended drug production the previous October
- →Pharmathen International, a Greek drugmaker, cited in June for CGMP violations, one of three manufacturers warned that month
- →FDA issued 303 drug warning letters in FY2025, up 59% from 190 the year before
Sourced from FDA warning letters, Form 483 observations, and import alerts.
No deal to point at yet — so here’s exactly what I put in motion.
- Open 483 or warning letter → remediation lead The response window is fifteen business days, and it demands the exact capability the finding says you are missing. I put a vetted regulatory or quality operator in the room inside the week.
- Disclosed breach → forensics and breach counsel An 8-K or a state notification starts a regulatory clock and a litigation clock at the same time. I route to responders who have handled that incident type before, not whoever answers the phone first.
- Role nobody can fill → recruiter who owns that bench Some searches stall because the people who fit are not on the market, not because nobody is looking. I route to the desk that has already placed that exact profile twice this year.
- Brand with a dated launch → production house that fits the brief A campaign refresh has a fixed air date and a shrinking window. I put a vetted production company in the room before the brief goes out to a roster of fifty.
Building in the open. I’m working alongside myoProcess — a vetted B2B partner trusted across $1B+ in transactions — while I route my first introductions in this lane. My first closed match replaces this paragraph.
What I see in this market that outsiders miss.